TOMI™ Completes SteraMist™ Technology Sales and Training for Two Additional Healthcare Systems

TOMI Environmental Solutions, Inc. (“TOMI” or the “Company”), (OTCQB: TOMZ), a global bacteria decontamination and infectious disease control company, announced today the completion of sale of TOMI™ patented Binary Ionization Technology® (“BIT”) to two more hospitals – Union Memorial of MedStar Health and Springhill Medical. TOMI™ has already trained staff members at each of these hospitals in the use of our BIT technology.

MedStar Health is the Maryland and Washington, D.C. areas largest regional healthcare system with a network of 10 hospitals and 20 other health-related businesses across the region. MedStar Health has more than 163,000 inpatient admissions and more than 2 million outpatient visits each year, as indicated from their website https://www.medstarhealth.org. Springhill Medical Center is a full service hospital serving southwest Alabama and includes a campus that is home to primary care physicians and is also a senior residence, sleep center, cancer center, athletic club, orthopedic surgery center, wound care and a hyperbaric center as indicated from their website http://www.springhillmedicalcenter.com.

About 1 in every 20 patients contracts an infection while in a hospital and, nationwide, 98,000 people die each year from hospital-acquired infections (“HAIs”), according to the Centers for Disease Control. Under the Affordable Care Act, hospitals will have a real financial incentive to deal with HAIs, as the federal government will reduce Medicare reimbursements to hospitals that have high infection rates starting in 2015, according to an article recently published by USA Today entitled, “Hospitals Face Whole New World Under Health Law.”

Dr. Halden Shane, TOMI’s Chief Executive Officer, stated, “We are excited and privileged that TOMI™ and its patented Binary Ionization Technology® and service have been chosen by these two hospital systems to provide solutions to combat killer hospital-acquired infections and otherwise be an integral component of each of these hospital’s environmental strategy for indoor surface decontamination.”

The TOMI™ technology is a decontamination system that applies cold plasma activation to a low percentage hydrogen peroxide-based aerosol, which then produces a Reactive Oxygen Species (“ROS”) mist that deactivates organic compounds and quickly inactivates viruses and bacteria including bacterial spores (C. diff) as well as mold spores, other fungi and yeast, both in the air and on surfaces. Leaving no residue or noxious fumes, SteraMist™ usage provides fast-acting, broad-spectrum decontamination, is environmentally friendly and is also safe for delicate medical equipment and computers.

About TOMI™ Environmental Solutions, Inc.

TOMI™ Environmental Solutions, Inc. (OTCQB: TOMZ) is a global bacteria decontamination and infectious disease control company, providing green energy-efficient environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide aerosols, Ultra-Violet Ozone Generators and Ultra-Violet Germicidal Irradiation ("UVGI") products and technologies.

TOMI™’s products are designed to service a broad spectrum of commercial structures including medical facilities, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, and athletic facilities. TOMI™’s products and services have also been used in single-family homes and multi-unit residences.

TOMI™ also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association and The International Ozone Association.

For additional product information, visit www.tomiesinc.com or contact us at info@tomiesinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.